This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 41042/0088.
AQUIPTA 10 mg and 60 mg tablets
AQUIPTA 10 mg tablets
AQUIPTA 60 mg tablets
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
1. What AQUIPTA is and what it is used for
2. What you need to know before you take AQUIPTA
3. How to take AQUIPTA
4. Possible side effects
5. How to store AQUIPTA
6. Contents of the pack and other information
AQUIPTA contains the active substance atogepant.
AQUIPTA works by blocking the activity of the calcitonin gene-related peptide (CGRP) molecule which has been linked to migraine. This reduction in CGRP’s activity reduces migraine attacks.
AQUIPTA is used to prevent migraine in adult patients who have at least 4 migraine days per month.
Talk to your doctor, pharmacist or nurse before taking AQUIPTA, especially if you:
Do not give this medicine to children or adolescents (under 18 years old) because the use of AQUIPTA has not been studied in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines may increase the risk of getting side effects.
The following is a list of examples of medicines that may require your doctor to lower the dose of AQUIPTA:
If any of the above apply to you or you are not sure, talk to your doctor or pharmacist before taking AQUIPTA.
AQUIPTA is not recommended during pregnancy.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
AQUIPTA may make you feel sleepy. Do not drive or use machines if you are affected.
This medicine contains 31.5 mg sodium (main component of cooking/table salt) in each 60 mg tablet. This is equivalent to 1.6% of the recommended maximum daily dietary intake of sodium for an adult.
This medicine contains less than 1 mmol sodium (23 mg) per 10 mg tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. Speak to your doctor or pharmacist if you are not sure.
The recommended dose is 60 mg once a day. Your doctor may tell you to take a lower dose if you are taking other medicines (listed in section 2) or if you have severe kidney problems. Speak to your doctor if you are undergoing dialysis.
AQUIPTA may be taken with or without food.
If you have used more AQUIPTA than you should, tell your doctor.
A missed dose should be taken straight away. If it is close to your scheduled next dose, do not take a double dose to make up for a forgotten tablet.
Do not stop using AQUIPTA without talking to your doctor first. Your symptoms may return if you stop the treatment.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor or nurse if you notice any of the following side effects:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is atogepant.
AQUIPTA 10 mg tablets
AQUIPTA 10 mg tablet is a white to off-white, round biconvex tablet debossed with “A” and “10” on one side.
AQUIPTA 60 mg tablets
AQUIPTA 60 mg tablet is a white to off-white, oval biconvex tablet debossed with “A60” on one side.
Each blister contains 7 tablets, each pack contains 28 or 98 tablets.
Not all pack sizes may be marketed.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in June 2023.
To listen to or request a copy of this leaflet in Braille, large print or audio, please contact the local representative of the Marketing Authorisation Holder.